“We attribute our continued success to our focus on exceptional customer service, as well as support from a stable leadership team."
(PRWEB) March 20, 2013
Enclara is taking its rightful place as one of the top leaders in hospice pharmacy. For the third consecutive year, Enclara has added an additional 5,000 patients to its footprint.
Established in 2007, Enclara has grown to service over 20,000 lives in 46 states, partnering with national hospices, such as Aseracare, as well as start-up organizations throughout the country, providing services in both the mail order and local Pharmacy Benefits Management market space.
Andy Horowitz, President and Founder, stated, “We attribute our continued success to our focus on exceptional customer service, as well as support from a stable leadership team. Our ability to ‘think out of the box’ with both our service models has positioned us to react to the reimbursement challenges that exist in the hospice industry today.”
Enclara continues to have the highest customer retention rate in the hospice pharmacy market, and has 2,600 ADC contracted for service through the beginning of 2013. "While we are proud of our growth last year, 2013 has proven to be our strongest start since we launched the business. We look forward to exceeding our growth of last year and that of our existing client’s expectations for exceptional customer service."
About Enclara Health
At Enclara Health, we support our hospice partners through cost effective, clinical excellence in both mail order and local pharmacy access. Enclara is committed to meeting the unique and changing needs of the hospice market and truly demonstrate that there is a difference in hospice pharmacy providers. For more information, visit http://www.enclarahealth.com.